Impairment of B-cell functions during HIV-1 infection
- PMID: 23595152
- DOI: 10.1097/QAD.0b013e328361a427
Impairment of B-cell functions during HIV-1 infection
Abstract
A variety of B-cell dysfunctions are manifested during HIV-1 infection, as reported early during the HIV-1 epidemic. It is not unusual that the pathogenic mechanisms presented to elucidate impairment of B-cell responses during HIV-1 infection focus on the impact of reduced T-cell numbers and functions, and lack of germinal center formation in lymphoid tissues. To our understanding, however, perturbation of B-cell phenotype and function during HIV-1 infection may begin at several different B-cell developmental stages. These impairments can be mediated by intrinsic B-cell defects as well as by the lack of proper T-cell help. In this review, we will highlight some of the pathways and molecular interactions leading to B-cell impairment prior to germinal center formation and B-cell activation mediated through the B-cell receptor in response to HIV-1 antigens. Recent studies indicate a regulatory role for B cells on T-cell biology and immune responses. We will discuss some of these novel findings and how these regulatory mechanisms could potentially be affected by the intrinsic defects of B cells taking place during HIV-1 infection.
© 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Similar articles
-
Mechanism(s) promoting HIV-1 infection of primary unstimulated T lymphocytes in autologous B cell/T cell co-cultures.Eur J Immunol. 2003 Aug;33(8):2098-107. doi: 10.1002/eji.200323932. Eur J Immunol. 2003. PMID: 12884283
-
Selective loss of T cell functions in different stages of HIV infection. Early loss of anti-CD3-induced T cell proliferation followed by decreased anti-CD3-induced cytotoxic T lymphocyte generation in AIDS-related complex and AIDS.Eur J Immunol. 1990 May;20(5):1039-44. doi: 10.1002/eji.1830200514. Eur J Immunol. 1990. PMID: 2162775
-
Altered expression of the tetraspanin CD81 on B and T lymphocytes during HIV-1 infection.Clin Exp Immunol. 2007 Jan;147(1):53-9. doi: 10.1111/j.1365-2249.2006.03250.x. Clin Exp Immunol. 2007. PMID: 17177963 Free PMC article.
-
B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design.Vaccine. 2008 Jun 6;26(24):3016-25. doi: 10.1016/j.vaccine.2007.11.063. Epub 2007 Dec 17. Vaccine. 2008. PMID: 18164520 Review.
-
Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease.J Allergy Clin Immunol. 2008 Jul;122(1):12-9; quiz 20-1. doi: 10.1016/j.jaci.2008.04.034. Epub 2008 Jun 10. J Allergy Clin Immunol. 2008. PMID: 18547629 Free PMC article. Review.
Cited by
-
HIV-associated memory B cell perturbations.Vaccine. 2015 May 21;33(22):2524-9. doi: 10.1016/j.vaccine.2015.04.008. Epub 2015 Apr 14. Vaccine. 2015. PMID: 25887082 Free PMC article. Review.
-
Diagnostic Performance of Tuberculosis-Specific IgG Antibody Profiles in Patients with Presumptive Tuberculosis from Two Continents.Clin Infect Dis. 2017 Apr 1;64(7):947-955. doi: 10.1093/cid/cix023. Clin Infect Dis. 2017. PMID: 28362937 Free PMC article.
-
HIV skews the SARS-CoV-2 B cell response towards an extrafollicular maturation pathway.Elife. 2022 Oct 27;11:e79924. doi: 10.7554/eLife.79924. Elife. 2022. PMID: 36300787 Free PMC article.
-
Frequency and phenotype of B cell subpopulations in young and aged HIV-1 infected patients receiving ART.Retrovirology. 2014 Sep 11;11:76. doi: 10.1186/s12977-014-0076-x. Retrovirology. 2014. PMID: 25213015 Free PMC article.
-
Antiretroviral naive and treated patients: Discrepancies of B cell subsets during the natural course of human immunodeficiency virus type 1 infection.World J Virol. 2016 Nov 12;5(4):155-160. doi: 10.5501/wjv.v5.i4.155. World J Virol. 2016. PMID: 27878102 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
